SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-013863
Filing Date
2022-08-02
Accepted
2022-08-02 16:03:59
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-20220630.htm   iXBRL 10-Q 4452196
2 EX-10.2 srpt-ex10_2.htm EX-10.2 38045
3 EX-31.1 srpt-ex31_1.htm EX-31.1 15160
4 EX-31.2 srpt-ex31_2.htm EX-31.2 15273
5 EX-32.1 srpt-ex32_1.htm EX-32.1 10854
6 EX-32.2 srpt-ex32_2.htm EX-32.2 10682
  Complete submission text file 0000950170-22-013863.txt   12420217

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20220630.xsd EX-101.SCH 66450
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20220630_pre.xml EX-101.PRE 353942
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srpt-20220630_cal.xml EX-101.CAL 71082
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srpt-20220630_def.xml EX-101.DEF 201811
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20220630_lab.xml EX-101.LAB 466027
75 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20220630_htm.xml XML 2336815
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 221128596
SIC: 2834 Pharmaceutical Preparations